The University of Western Australia

UWA Staff Profile

Ipsum Lorem

Ms Erin Kelty

Research Associate
Population and Public Health

Contact details
Address
Population and Public Health
The University of Western Australia (M431)
35 Stirling Highway
CRAWLEY WA 6009
Australia
Phone
+61 8 6488 8667
Email
erin.kelty@uwa.edu.au

Research Associate
Health Services Research, Centre for

Contact details
Address
Centre for Health Services Research
The University of Western Australia (M431)
35 Stirling Highway
CRAWLEY WA 6009
Australia
Phone
+61 8 6488 8667
Email
erin.kelty@uwa.edu.au
Publications
Kelty, E., & Hulse, G. (2017). Rates of hospital and emergency department attendances in opiate dependent patients treated with implant naltrexone, methadone, or buprenorphine. Addictive Disorders & Their Treatment, In Press.
Kelty E. Dobbins T. & Hulse G. (2017) Incidence of cancer and cancer related mortality in opiate dependent patients treated with methadone, buprenorphine or implant naltrexone as compared with non-opiate using controls. Heroin Addiction and Related Clinical Problems, In Press.
Martinez, F. E., Anstey, M., Ford, A., et al. (2017). Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial. [journal article]. Trials, 18(1), 4.
Cumming C., Troeng L., Young J., Kelty E. & Preen D. (2016) Barriers to accessing methamphetamine treatment: A systematic review and meta-analysis Drug and Alcohol Dependence. Drug and Alcohol Dependence. 168: 263 - 273.
Tait RJ., Teoh L., Kelty E. et al (2016) Emergency department based intervention with adolescent substance users: 10 year economic and health outcomes. Drug and Alcohol Dependence. 165: 168 - 174.
Hulse GK., Kelty E., Hood S. et al. (2015) Novel indications for benzodiazepine antagonist flumazenil in GABA mediated pathological conditions of the central nervous system. Current Pharmaceutical Design. 21: 3325 - 3342.
Martinez EF, Panwar R, Kelty E, et al. (2015) Idiopathic Interstitial Pneumonia in ICU: An observational study. Anaesthesia and Intensive Care. 43(6): 707 - 711.
Hancock DB, Levy JL, Gaddis NC, et al. (2015) Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. Biological Psychiatry. 78(7): 474 - 84.
Martinez FE and Kelty E. (2015) Attitudes toward reciprocity, preferred status and other organ donation policies: a survey of the Australian and New Zealand intensive care community. Anaesthesia and Intensive Care 43: 132-133.
Kelty E, Hayes L, O'Neil G, et al. (2014) Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use. Journal of Psychopharmacology 28: 745-750.
Kelty E, Martyn V, O’Neil G, et al. (2014) Use of subcutaneous flumazenil preparations for the treatment of idiopathic hypersomnia: A case report. Journal of Psychopharmacology 28: 703 - 706.
Kelty E., Ngo H. T. T. & Hulse G. (2013) Assessing the usefulness of health data linkage in obtaining adverse event data in a randomised controlled trial of oral and implant naltrexone in the treatment of heroin dependence. Clinical Trials, 10 (1), 170 - 180.
Kelty E., Thomson K., Carlstein S., Sinclair R. & Hulse G. (2013) “A retrospective assessment of the use of naltrexone implant for the treatment of problematic amphetamine use” American Journal of Addictions, I22 (1), 1 – 6.
Kelty E. & Hulse G. (2012) Examination of Mortality Rates in a Retrospective Cohort of Patients treated with Oral or Implant Naltrexone for Problematic Opiate Use. Addiction, 107, 1817 - 1824.
Kelty E., Nicholls P. K., O'Neil, G., Harrison Z., Chan C.-T., Symons P., Reece A. S. & Hulse G. (2012) The occurrence of spontaneous lymphomas but not adenomas or sarcomas in rats treated with sustained release naltrexone. Clinical and Experimental Pharmacology, 1 (2), 1 - 7.
Research profile
Research profile and publications
 

The University of Western Australia

This Page

Last updated:
Tuesday, 3 November, 2015 2:39 PM